-+ 0.00%
-+ 0.00%
-+ 0.00%

*Akebia Therapeutics Had Cash and Cash Equivalents of $113.4M as of the End of the Qtr >AKBA

Dow Jones·05/08/2025 11:04:00

Please log in to view news